A $50 M. Picasso in Paris, and Gagosian’s Biggest Pet Peeve: Industry Moves for October 22, 2025October 23, 2025
Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO